KyeongJin Kim

7PUBLICATIONS
24CO-AUTHORS
Metabolic medicineGene and molecular therapyProteomics and intermolecular interactions (excl. medical proteomics)Genome structure and regulationNanophotonics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 28, 2026
E3 Ubiquitin Ligases in MASH-Associated Liver Fibrosis: Mechanisms and Therapeutic Opportunities.

|Oct 27, 2025
Focus on Semaglutide 2.4 mg/week for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis.

Salvatore Petta, KyeongJin Kim, Giovanni Targher

|Jul 31, 2025
Hepatocyte KCTD17-mediated SERPINA3 inhibition determines liver fibrosis in metabolic dysfunction-associated steatohepatitis.

Yelin Jeong, Ah-Reum Oh, Young Hoon Jung

|Oct 01, 2023
Targeting E3 ubiquitin ligases and their adaptors as a therapeutic strategy for metabolic diseases.

Yelin Jeong, Ah-Reum Oh, Young Hoon Jung

|Apr 20, 2022
Regulated interaction of ID2 with the anaphase-promoting complex links progression through mitosis with reactivation of cell-type-specific transcription.

Sang Bae Lee, Luciano Garofano, Aram Ko

|Jun 24, 2021
Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis.

Junjie Yu, Changyu Zhu, Xiaobo Wang

Pageof 2

Frequent Collaborators

3 joint publications

Sang Bae Lee

2 joint publications

Utpal B Pajvani

2 joint publications

Luca Valenti

1 joint publications

Junjie Yu